Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
EMMPRIN-mediated MMP regulation in tumor and endothelial cells
Authors
Stéphanie Caudroy
Myriam Polette
Béatrice Nawrocki-Raby
Jian Cao
Bryan P. Toole
Stanley Zucker
Philippe Birembaut
Publication date
01-12-2002
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/2002
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1021350718226

Other articles of this Issue 8/2002

Clinical & Experimental Metastasis 8/2002 Go to the issue

OriginalPaper

Effects of Celebrex and Zyflo on liver metastasis and lipidperoxidation in pancreatic cancer in Syrian hamsters

OriginalPaper

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer

OriginalPaper

Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice

OriginalPaper

Role of integrin αvβ3 in the early phase of liver metastasis: PET and IVM analyses

OriginalPaper

A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful?

OriginalPaper

Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: Relation to invasion
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits